* Bio Rad Laboratories Inc BIO.N reported quarterly
adjusted
earnings of $3.10 per share for the quarter ended in December,
lower than the same quarter last year, when the company reported
EPS of $3.31. The mean expectation of six analysts for the
quarter was for earnings of $2.82 per share. Wall Street
expected results to range from $2.58 to $3.00 per share.
* Revenue fell 6.7% to $681.18 million from a year ago;
analysts
expected $685.09 million.
* Bio Rad Laboratories Inc's reported EPS for the quarter
was
$12.14.
* The company reported quarterly net income of $349.71
million.
* Bio Rad Laboratories Inc shares had risen by 1.6% this
quarter.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 1.5%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "buy"
Wall Street's median 12-month price target for Bio Rad
Laboratories Inc is $400.00
This summary was machine generated from LSEG data February 15 at
10:38 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2023 2.82 3.10 Beat
Sep. 30 2023 2.78 2.33 Missed
Jun. 30 2023 2.68 3.00 Beat
Mar. 31 2023 3.54 3.34 Missed